Gewählte Publikation:
Benedikt, M.
Modern Anti-Diabetics in Cardiovascular Disease
Doktoratsstudium der Medizinischen Wissenschaft; Humanmedizin; [ Dissertation ] Medizinische Universität Graz; 2025. pp. 132
[OPEN ACCESS]
FullText
- Autor*innen der Med Uni Graz:
- Betreuer*innen:
-
Scherr Daniel
-
von Lewinski Dirk
-
Wallner Markus
- Altmetrics:
- Abstract:
- The clinical study "Empagliflozin in Acute Myocardial Infarction" (EMMY) was the first to demonstrate positive effects of empagliflozin on cardiac parameters. However, data regarding its effects on inflammation, echocardiographic parameters, and arrhythmias are lacking. The aim of this work is to analyse the effects of sodium-glucose cotransporter-2 inhibitors (SGLT2-I) on inflammatory markers, echocardiographic parameters, and arrhythmic burden, and to investigate whether initial electrocardiogram (ECG) values are predictive of changes in cardiac markers following acute myocardial infarction (AMI).